Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 February 2024 | Story ANTHONY MTHEMBU | Photo ROSINA MOTHIBA
Prof Makgalwa
Prof Matseliso Mokhele-Makgalwa: Vice Dean; Research, Engagement and Internationalisation in the Faculty of Education at the University of the Free State (UFS).

The Faculty of Education at the University of the Free State (UFS) proudly announces the appointment of Prof Matseliso Mokhele-Makgalwa as Vice Dean of Research, Engagement and Internationalisation, effective 1 January 2024. With a wealth of experience and a fervent dedication to academic advancement, Prof Mokhele-Makgalwa’s appointment marks a significant stride towards enhancing the faculty’s global presence and academic prowess. 

Transitioning into a new role

Transitioning seamlessly from her previous role as Acting Vice Dean of Research and Postgraduate Studies, Prof Mokhele-Makgalwa perceives this new appointment as a natural progression, elevating her responsibilities to spearhead research endeavours, foster engagement, and cultivate international partnerships within the faculty. Embracing this pivotal role with enthusiasm, she underscores the importance of collaborative efforts among faculty members, securing research funding, and ensuring the quality and impact of scholarly outputs. 

“I appreciate the opportunity to contribute significantly to the faculty’s research, engagement and internalisation efforts,” says Prof Mokhele-Makgalwa. “I look forward to collaborating with the faculty staff members to advance our academic initiatives on a broader scale.”  

A vision of progression for the faculty

At the heart of her vision lies a commitment to realise the UFS’s Vision130, wherein Prof Mokhele-Makgalwa aims to elevate the international profile of the faculty, foster impactful research, promote engaged scholarship, and facilitate knowledge exchange on a global scale. Her strategic objectives also include positioning the faculty among the top three education schools nationally, reflecting her dedication to academic excellence and institutional advancement. 

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept